Menu
location_on
Location

India

category
Sector

Nutrition, Health

monetization_on
Type of Investment

Grant

timeline
Project Stage

Test & Transition

schedule
Length of Investment

2017-2020

Investment Overview

J-PAL South Asia planned to conduct a randomised controlled trial (RCT) in Tamil Nadu, India, to test whether the distribution of free fortified rice through the Public Distribution System (PDS) is a cost-effective way to treat anaemia at scale.

psychology_alt

The Development Challenge


Anaemia is the most common form of malnutrition, affecting approximately 1.6 billion people worldwide. In Tamil Nadu, anaemia affects 60% of children between six months and five years of age, and more than half of pregnant women. Despite research showing that dietary iron and other micronutrients can help to alleviate the problem, in practice they are often ineffective as their usage relies on recipients actively using them.


lightbulb

The Innovation


J-PAL South Asia’s innovation planned on replacing conventional rice provided free of charge through the Indian PDS with fortified rice kernels made from rice flour enriched with iron, zinc, vitamin A, folic acid, and B vitamins blended with parboiled rice. Whereas other programmes require people to remember to take iron pills, or to go out of their way to buy fortified food, this intervention involved no behavioural change from consumers.


account_balance

Our Investment

GIF’s grant of USD 1.23 million was used to test whether the distribution of fortified rice through the PDS is a cost-effective way to treat anaemia at scale. The J-PAL team also wished to collect information, carry out implementation and advocacy activities, and produce guidance to facilitate the potential scale-up of the intervention by the Government of Tamil Nadu.

currency_exchange

Progress to date

Unfortunately, this investment was closed in late 2020 following several challenges that prevented the distribution of the fortified rice from being successfully launched. These included a change in the standards set by the Food Safety and Standards Authority of India (FSSAI) in 2018, a setback in testing nutrient levels (2019), and travel restrictions during the Covid-19 pandemic (2020).

calculate

Reducing Anemia in numbers

1/3

Malnourished children globally are in India

$540,000

GIF grant

lab_profile

Reducing Anemia Completion Brief

The innovation being tested in this study was the distribution of fortified rice via the already existing Public Distribution System (PDS) that delivers free rice to all households in the Indian state of Tamil Nadu for an increased intake of iron and micronutrients to tackle the endemic issue of anaemia. Whereas other programmes require people to remember to take iron pills, or to go out of their way to buy fortified food, this intervention involved no behaviour change from consumers.

Use of GIF Funds

GIF provided $540,000 funding to cover:

  • The work of research and implementation personnel
    • The two arms of the RCT:

    • Treatment arm of 110 villages that were to receive fortified rice

  • Control arm of 110 villages that were to receive normal (unfortified) rice

  • Data collection and analysis costs

  • Cost for a Project Implementing Agency (third-party agency), responsible for quality control and supervision

  • Policy dissemination costs

  • Equipment, supplies, travel, and other project costs.

Objectives

This project aimed to address anaemia and micro-nutrient deficiencies in the Indian state of Tamil Nadu. The intervention involved replacing conventional rice provided free of charge through the PDS with fortified rice made from rice flour enriched with iron, zinc, vitamin A, folic acid, and B vitamins blended with parboiled rice.

Impact to Date

Unfortunately this investment was closed in late 2020 following a number of challenges that prevented the distribution of the fortified rice from being successfully launched. These included a change in the standards set by the Food Safety and Standards Authority of India (FSSAI) in 2018, a setback in testing nutrient levels (2019), and travel restrictions during the Covid-19 pandemic (2020).